Global Blood Testing Market Size (2024 - 2029)

The blood testing market is projected to experience significant growth over the forecast period, driven by factors such as the increasing prevalence of chronic diseases, the rising demand for home healthcare, and the introduction of advanced technology-enabled products. The need for early and effective diagnosis of conditions like cancer and dengue is fueling this expansion, as timely blood testing is crucial for managing these diseases. Additionally, favorable government initiatives and increased research and development expenditures are contributing to the market's growth. However, the market's expansion may be challenged by a stringent regulatory approval process.

Market Size of Global Blood Testing Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Blood Testing Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 90.62 Billion
Market Size (2029) USD 126.12 Billion
CAGR (2024 - 2029) 6.88 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Blood Testing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Blood Testing Market Analysis

The Global Blood Testing Market size is estimated at USD 90.62 billion in 2024, and is expected to reach USD 126.12 billion by 2029, growing at a CAGR of 6.88% during the forecast period (2024-2029).

Factors such as the growing burden of chronic diseases, rising demand for home healthcare, the introduction of advanced technology-enabled products, the implementation of favorable government initiatives, and rising research and development expenditures on developing blood tests are expected to drive the market.

Blood, plasma, and serum are the most important elements in the body's circulation system. These are also widely studied for the detection of biomarkers, especially for cancer detection and early diagnosis. The growing burden of several chronic diseases increased the demand for their early and effective diagnosis, as delay in diagnosis may lead to complications that can be fatal. For instance, according to the National Breast Cancer Foundation's April 2024 update, approximately 1 in 8 women in the United States is expected to face a breast cancer diagnosis during their lifetime. For 2024, projections suggest that around 310,720 women and 2,800 men will receive diagnoses of invasive breast cancer. The huge prevalence of cancer cases worldwide requires regular monitoring and diagnosing of these diseases, which is expected to fuel the market growth during the forecast period.

According to the European Centre for Disease Prevention and Control's January 2023 publication, up to December 31, 2022, 4,110,465 cases of dengue were reported. The majority of cases were reported from Brazil (2,363,490), Vietnam (367,729), the Philippines (220,705), Indonesia (125,888), and India (110,473). Early detection of disease progression associated with severe dengue boosts the demand for blood testing for timely diagnosis of the diseases, thus driving the market. Furthermore, product launches by market players are expected to propel the market's growth over the forecast period. For instance, in June 2022, in association with Datar Cancer Genetics, Apollo Cancer Centers introduced a blood test to detect breast cancer early in asymptomatic individuals. The test, EasyCheck-Breast, can help detect breast cancer even before the first stage.

Thus, the market is expected to grow significantly during the forecast period due to the above-mentioned factors. However, a stringent regulatory approval process is expected to hinder market growth during the forecast period.

Blood Testing Industry Segmentation

As per the scope of the report, blood testing is an analysis conducted in a laboratory, with the main aim of determining the general state of health, the presence of harmful bacteria or viruses, and assessing disease progression. Some of the major diseases that require blood testing are cancer and AIDS/HIV.

The blood testing market is segmented by type, method, end user, and geography. By type, the market is segmented into glucose testing, lipid panel testing, prostate-specific antigen (PSA) testing, blood urea nitrogen (BUN) testing, thyroid stimulating hormone testing, and other types. By method, the market is segmented into manual blood testing and automated blood testing. By end user, the market is segmented into manual blood testing and automated blood testing. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (USD) for all the above segments.

By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End User
Diagnostic Laboratories
Hospitals
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Blood Testing Market Size Summary

The blood testing market is poised for significant growth over the forecast period, driven by several key factors. The increasing prevalence of chronic diseases, such as cancer and diabetes, has heightened the demand for early and effective diagnostic solutions, which blood tests provide. The market is also benefiting from the rising demand for home healthcare and the introduction of advanced technology-enabled products. Favorable government initiatives and increased research and development expenditures further support market expansion. The need for regular monitoring and diagnosis of diseases, particularly cancer, is a major driver, as delays in diagnosis can lead to severe complications. Additionally, the demand for blood testing is bolstered by the necessity for timely diagnosis of diseases like dengue, which has seen a rise in cases globally.

North America is expected to maintain a significant share of the blood testing market, largely due to technological advancements and favorable medical insurance policies that enhance product adoption. The United States, in particular, is anticipated to dominate the market, driven by the high burden of chronic diseases requiring blood tests. The presence of portable glucose meters and the rising prevalence of diabetes further contribute to the growth of the glucose testing segment. The market is characterized by fragmentation, with major players like Danaher Corporation, BioRad Laboratories, and Abbott Laboratories actively engaging in strategic initiatives such as mergers, acquisitions, and new product launches to strengthen their market positions. These companies are also involved in launching technologically advanced blood tests, which are expected to positively impact market growth.

Explore More

Global Blood Testing Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Burden of Chronic Diseases

      2. 1.2.2 Rising Demand for Home Healthcare and the Introduction of Advance Technology-enabled Products

      3. 1.2.3 Implementation of Favorable Government Initiatives & External Funding for R&D Exercises

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Approval Process

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size By Value - in USD)

    1. 2.1 By Type

      1. 2.1.1 Glucose Testing

      2. 2.1.2 Lipid Panel Testing

      3. 2.1.3 Prostate Specific Antigen (PSA) Testing

      4. 2.1.4 Blood Urea Nitrogen (BUN) Testing

      5. 2.1.5 Thyroid Stimulating Hormone Testing

      6. 2.1.6 Other Types (Direct LDL testing, Testosterone Testing)

    2. 2.2 By Methods

      1. 2.2.1 Manual Blood Testing

      2. 2.2.2 Automated Blood Testing

    3. 2.3 By End User

      1. 2.3.1 Diagnostic Laboratories

      2. 2.3.2 Hospitals

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Blood Testing Market Size FAQs

The Global Blood Testing Market size is expected to reach USD 90.62 billion in 2024 and grow at a CAGR of 6.88% to reach USD 126.12 billion by 2029.

In 2024, the Global Blood Testing Market size is expected to reach USD 90.62 billion.

Blood Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)